Navigation Links
DATATRAK Signs New Client for Rescue Study
Date:11/10/2009

CLEVELAND, Nov. 10 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the award of a Phase III rescue study with a new client, Symbio, LLC. A CRO specializing in dermatology, Symbio will be utilizing DATATRAK eClinical's(TM) hybrid functionality - double data entry and EDC. In an effort to meet the timelines of this fast-track project, Symbio will enter data previously gathered on paper through eClinical's Clinical Data Management component, while new patient data will be captured electronically via eClinical's Electronic Data Capture component.

"Symbio's commitment to being a collaborative resource partner is exemplified by their innovative approach of designing a solution to utilize data previously thought useless. By utilizing DATATRAK eClinical(TM) to collect data from the initial study and data from the rescue study, Symbio will be able to quickly and efficiently provide their client with valuable data for analysis," said Laurence Birch, DATATRAK's Chairman of the Board. "This study exemplifies eClinical's ability to streamline the clinical trial process with the end-to-end clinical data management functionality necessary for conducting EDC and paper studies."

"Symbio is thrilled with the opportunity to collaborate with DATATRAK on this important project. With timing as the priority for our sponsor, DATATRAK will assist us in providing the clinical study report as quickly as possible. eClinical will enable us to provide real time data to the sponsor and streamline the data capture activities from the sites. We are fortunate for this collaboration and look forward to future endeavors," stated Betsey Zbyszynski, Director of Client Services.

About Symbio

Symbio is a full service CRO with a Phase I-IV clinical site that is dedicated to meet and exceed clinical developm
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. DATATRAK International, Inc. to Release 2009 Second Quarter and First-Half Operating Results on August 17, 2009
2. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
3. Quantel Signs a Distribution Agreement With US-based National Biological
4. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
5. Cell Biosciences Signs Agreement to Acquire Alpha Innotech
6. Fauve Intertrade Signs Major Energy Contracts in China
7. SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company
8. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
9. Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
10. Dendreon Signs Lease for New Manufacturing Facility in Atlanta
11. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Research ... "Global Enzyme for Pulp & Paper Industry Report ... The Global Enzyme for Pulp & Paper Industry Report ... current state of the global enzyme for pulp & ... overview of the industry including definitions, classifications, applications and ...
(Date:8/27/2014)... Palm Beach County, Florida (PRWEB) August 27, 2014 ... & Company Inc. (SCI) is announcing the creation ... board’s priority is to take the SCI’s philosophy ... insuring the company’s research and development actions are ... interpretations. , This new Scientific Advisory Board provides ...
(Date:8/27/2014)... College, PA (PRWEB) August 27, 2014 ... Simulation Software with new features for the biomedical ... is an enhanced Biological Thermal Sensor, exclusive to the ... a specialty version of XFdtd, developed to calculate the ... export functionality has been added to all versions to ...
(Date:8/26/2014)... 26, 2014  NeuroSigma, Inc., a Los ... bioelectronic technologies, today announced that it has filed a ... and Exchange Commission relating to a proposed initial public ... to be offered and the price range for the ... Jefferies LLC will act as the book-running manager for ...
Breaking Biology Technology:Global Enzyme for Pulp & Paper Industry Report 2014 2New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3
... 3 Sangamo BioSciences,Inc. (Nasdaq: SGMO ) announced ... will provide an update on the progress of,Sangamo,s ZFP ... strategy at 12:45pm (PT) on Wednesday, October 10, 2007,at ... will be webcast live and may be accessed via ...
... Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), a biopharmaceutical ... candidates principally,for use in the hospital setting, announced ... will present the corporate overview on,Wednesday, October 10, ... Eastern Time),during the BIO Investor Forum in San ...
... Laboratories to 45%, GURGAON, India, Oct. 3 ... announced the,signing of Definitive Agreements, providing for an increase ... 45% at a price of Rs. 160 per share,aggregating ... of shares from the existing Promoters (b) Preferential ...
Cached Biology Technology:Sangamo BioSciences to Present at the 2007 BIO InvestorForum 2Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BIO Investor Forum 2Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology 2Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology 3
(Date:8/27/2014)... Outstanding basic research, a growing focus on translating ... care have earned the Herbert Irving Comprehensive Cancer ... and NewYork-Presbyterian Hospital an $18 million, five-year Cancer ... (NCI). The grant renews the center,s status as ... in New York City and one of only ...
(Date:8/27/2014)... of studies have shown that excessive iron ... Parkinson,s disease. Previous studies from Chunyan Guo ... China have shown that baicalin prevented iron ... metal transporter 1 expression, and increased ferroportin ... rotenone-induced Parkinson,s disease rats. However, the relationship ...
(Date:8/27/2014)... ago the Happy Camp Complex of fires had consumed ... complex had consumed 35,530 as of eight hours ago. ... Happy Camp Ranger District of the Klamath National Forest ... 11, 2014. All but three of those fires are ... of contained fires and their size at containment: Delta, ...
Breaking Biology News(10 mins):Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4Happy Camp and July Fire Complexes in California 2
... The TWAS 22nd General Meeting will take place on ... Theoretical Physics (ICTP), home to the Academy,s secretariat. TWAS,s ... by Romain Murenzi, executive director of TWAS; Fernando Quevedo, ... Affairs, Italy; and Jacob Palis, TWAS President, will highlight ...
... American Heart Association will today present Gladstone Institutes ... PhD, with the 2011 AHA Distinguished Scientist Award, ... founding cardiovascular scientists. The Distinguished Scientist Award ... Association can give a scientist. Dr. Mahley is ...
... 2 million people each year, is caused primarily by infectious ... Mtb . Mtb targets human immune cells as ... body,s immune response. Up until now, scientists ... the Immunity and Infection Research Centre at Vancouver Coastal Health ...
Cached Biology News:TWAS 22nd General Meeting in Trieste 2Gladstone founder receives American Heart Association Distinguished Scientist Award 2Researchers uncover why the body can't defend against tuberculosis 2